Our leadership expertise is rooted in population health management, laboratory medicine, finance and operations. We have achieved success for over 30 years and have laid the groundwork for what has become one of the nation’s premier biometric screening and wellness companies. The executive leadership team founded a national cost-effective biometric/flu voucher program offering that will be available at local retail pharmacies throughout the United States. We are a company that understands and responds to the marketplace. At Impact Health, our clients find these to be invaluable attributes when selecting and partnering with a biometric screening company.
Mike has served as the CEO of Impact Health since 2000. His extensive background in both the consumer products and pharmaceutical industries, combined with his commitment to bringing health promotion and wellness services at the consumer level were a perfect fit for Impact Health as it was expanding its reach into new arenas. Mike was a founding officer of AmerisourceBergen, a Fortune 15 company, and brings his vast experience in business development activities, acquisitions, enterprise-wide sales and marketing to the company. He has been instrumental in overseeing a multi-million dollar growth in revenue during his tenure and continues to move the company forward, by proactively positioning the organization to meet client needs.
Jim joined Impact Health as Vice President and Chief Financial Officer in March 2000. Prior to Impact Health, Jim served as Chief Financial Officer, Vice President General Manager Finance, and Corporate Controller during a six-year tenure for National Media Corporation (NMC – later known as e4L, Inc.), a publicly held global company engaged in the use of direct response transactional programming, wholesale/retail distribution and electronic commerce to sell consumer products. At National Media, Jim was responsible for internal/external reporting, budgeting, treasury, financial planning, M&A activity and banking relationships. Before joining NMC, Jim spent 14 years with Ernst &Young, working with clients ranging from billion dollar SEC companies to smaller start-up entities in the distribution, manufacturing, healthcare, financial services, retail and technology industries. Jim is a graduate of LaSalle University.
Impact Health is a leading national biometric, health and wellness organization that also specializes in COVID-19 solutions, vaccine immunization and cognition screenings. As Executive Vice-President of Sales, Marketing and Business Development, I am responsible for leading a highly acclaimed industry expert sales team specializing in COVID-19 solutions, biometric screenings and vaccine immunizations. Utilizing my can-do attitude, coupled with a successful record of mergers and acquisitions, I am working to best position Impact Health for the future.
With over 30 years of experience as a serial entrepreneur in the medical and pharmaceutical industry, my chief responsibility is strategically developing, initiating and implementing Impact Health’s sales, marketing and business development objectives and initiatives.
As a registered pharmacist, with extensive experience and leadership in various- noteworthy industry board positions, I was one of the founders and President of United Managed Care which covered in excess of 2 million lives and 1400 pharmacies. Previously I spent over 10 years as a Vice President for Henry Schein leading the Vaccine Marketing and Merchandising, Medical Corporate Accounts and Pharmaceutical Business Development efforts there.
Dr. Gerson serves as Impact Health’s Chief Medical Officer. He is an experienced medical professional with a demonstrated history of working in the hospital & health care industry. His areas of professional expertise are in Epidemiology, Medical Devices, Oncology, Toxicology, Sleep Disorders, Biotechnology, and Health Services & Research. He is a graduate of the Johns Hopkins University School of Medicine. He has involvement with the National Sleep Foundation, the Medical Review Officers Certification Council (MROCC), Sleep Inc., the Opioid Advisory Committee, and the National Safety Council. He has been a professor at Harvard Medical School, Boston University School of Medicine and Thomas Jefferson Medical College.
Ms. Collins serves as Impact Health’s VP, Regulatory and Compliance. She has a 30-year clinical background and work history of implementing technology for laboratory quality assurance and HIPAA compliance for point-of care laboratories. She provides regulatory and compliance guidance at the federal and state levels.